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1 |  CASE HISTORY
A 9-year 1-month-old spayed female Labrador Retriever 
dog weighing 33  kg presented for investigation of three 
generalized tonic-clonic epileptic seizures that occurred 
1 and 2  months prior to referral; the second and third sei-
zures presented as clusters. Normal interictal periods were 
documented. The dog was receiving thyroxine supplementa-
tion (Thyforon 400 µg tablets; Dechra Veterinary Products) 
(15  µg/kg PO q24 h) and meloxicam treatment (Loxicom 
1.5  mg/mL oral suspension, Norbrook® Laboratories Ltd.) 
(0.1 mg/kg PO q24 h) for previously diagnosed hypothyroid-
ism and osteoarthritis, respectively. The referring veterinar-
ian had prescribed phenobarbital (Epiphen 60  mg tablets; 
Vetoquinol UK Ltd) (2 mg/kg PO q12 h) after the last ES. 
The serum phenobarbital concentration 2 weeks after com-
mencing the anti-epileptic therapy was 26.8 mg/L (reference 
range, 25-30 mg/L for idiopathic epilepsy). Physical exam-
ination revealed mild stiff gait on the thoracic limbs, com-
patible with the aforementioned osteoarthritis. Neurological 
examination was considered normal, except for mild discom-
fort upon rostral skull palpation. Based on the patient's age, 
structural epilepsy was suspected.
Complete blood count revealed mild normocytic, nor-
mochromic, and nonregenerative anemia (hematocrit: 
30%; reference range, 35%-55%) and mild thrombocytosis 
(478 × 109/L; reference range, 150-400 × 109/L). Serum bio-
chemistry revealed increased alkaline phosphatase (326 U/L; 
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Solitary osseous plasmacytomas affecting the vertebrae, the zygomatic arch, and ribs 
occur in dogs. In this report, we describe clinical and imaging features of a soli-
tary osseous plasmacytoma affecting the skull with deposition of amyloid forming 
a mass-like lesion. To the authors' knowledge, no similar cases have been reported 
before.
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reference range, 0-100  U/L) and alanine transaminase 
(67  U/L; reference range, 15-60  U/L). These clinicopatho-
logical changes were most likely secondary to phenobarbi-
tal administration. Urinalysis detected no abnormalities. The 
urine protein: creatinine ratio was normal (0.08; reference 
range, <0.2).
Magnetic resonance imaging (MRI) of the head was per-
formed with a 1.5 T MRI scanner (Ingenia 1.5T CX; Philips 
Medical System). Several sequences (T2W, T1W, T2*, 
FLAIR, DWI) in multiple planes were acquired. An extensive 
lobulated and infiltrative mass was identified centered on the 
frontal and parietal bones, bilaterally. Large lobules were ex-
tending into both frontal sinuses filling most of their lumina 
(Figure 1 open arrow). The lobules showed a marbled, mixed 
hyper-/hypointensity (compared with gray matter) pattern on 
T2W, T1W, and FLAIR images (Figure 2A-C asterisk) with 
some suspected cystic areas within the lobules with marked, 
also heterogeneous contrast enhancement postgadolinium 
injection (0.1  mmol/kg gadobutrol, Gadovist 1.0  mmol/
mL; Bayer; Figure 2D arrowheads). The normal T2W- and 
T1W-hyperintense signal (fat) of diploe was replaced by hy-
pointense (compared with normal diploe) tissue. This tissue 
showed mild to moderate heterogeneous contrast enhance-
ment. Within the internal table of the parietal and frontal 
bones punctate to moth-eaten areas of lysis were present. 
The adjacent meninges enhanced markedly after contrast ad-
ministration (Figure 2D). Additionally, another broad-based 
extra-axial mass was noted to expand from the region of left 
parietal bone into the left brain parietal lobe (Figure 2A-D 
white arrow), displacing the cortical gray matter and com-
pressing the adjacent gyri. The mass effect was however 
minimal. The mass was T2W and T2* hyperintense and did 
not suppress on FLAIR images. On T1W images, the mass 
was hypointense with a ventrolateral curvilinear hyperintense 
rim. The nature of this rim remained unclear. There was mild 
to moderate patchy central enhancement postcontrast admin-
istration (Figure 2D white arrow). The overlying meninges 
were markedly thickened and enhancing (Figure  2D open 
arrow). This mass was presumed an extension of the calvarial 
mass. Cerebrospinal fluid analysis was declined by the own-
ers. A neoplastic disease of osseous origin was suspected. 
Toxoplasma gondii IgG and IgM (<50 and <20, respectively) 
and Neospora caninum IgG (<100) serum titers were not 
suggestive of an active infection. Cryptococcus spp. antigen 
testing was negative. Thoracic and abdominal radiographs 
(FCR XG-1; FUJIFILM Medical Systems) revealed no os-
teolytic lesions or clinically significant abnormalities. Six 
weeks after presentation, incisional biopsy from the left pari-
etal bone and underlying left intracranial mass were obtained 
via left rostro-tentorial craniectomy. During the postopera-
tive period, the dog suffered from a generalized tonic-clonic 
epileptic seizure. Levetiracetam (levetiracetam 500  mg 
tablets; Milpharm Ltd.) (20 mg/kg PO q 8h) treatment was 
commenced. No postoperative neurological deficits were de-
tected upon examination. Histopathological analysis of the 
skull sample revealed fragments of trabecular bone and large 
hematopoietic tissue. The latter was expanded by the infil-
trative growth of a monomorphic population of discrete neo-
plastic cells associated with scant fibrovascular stroma. Cells 
had a scant to moderate light basophilic cytoplasm and cen-
trally placed round vesicular nucleus with large eosinophilic 
nucleolus. Mitotic activity was 2-3/high-power field and cel-
lular atypia was mild (Figure 3). Immunohistochemical ex-
amination indicated the presence of numerous CD79α+ and 
MUM-1-positive cells within the neoplastic population. The 
histolopathological examination of the subjacent intracranial 
tissue indicated the presence of pale eosinophilic material re-
sembling amyloid intercalated/surrounded by small perivas-
cular aggregates of lymphocytes. No meninges or cerebral 
cortex was identified in the sampled tissues.
A provisional diagnosis of solitary osseous plasmacytoma 
with subjacent amyloid deposition was established, and stag-
ing workup was therefore extended to exclude presence of 
distant tumor involvement. Radiographs of the four limbs 
showed no evidence of bone lesions. An ultrasound scan 
(RS80A; Samsung Medison Co. Ltd.) revealed normal ap-
pearance of the medial retropharyngeal, parotid, and mandibu-
lar lymph nodes, mild splenomegaly, and changes compatible 
with a right caudal pole renal infarct. Cytology examination 
of the medial retropharyngeal lymph nodes, liver, spleen, and 
bone marrow was performed by means of ultrasound-guided 
fine needle aspirates (FNA); and no evidence of plasma cell 
neoplasia was detected. Serum protein electrophoresis was 
also performed and revealed no abnormalities.
F I G U R E  1  Left parasagittal T2W magnetic resonance image of 
the brain of the dog. A large, bulbous mass of heterogeneous signal 
intensity (open arrow) is present within the left frontal sinus. The 
infiltrative component is extending caudally into the diploe of the 
frontal and parietal bone. A broad-based, well-defined, extra-axial, 
T2W-hyperintense mass (white arrow) is noted within the parietal lobe 
ventral to the abnormal parietal bone
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Considering the imaging and the clinicopathological 
findings, a diagnosis of solitary osseous plasmacytoma with 
extensive calvarial involvement and subjacent intracranial 
amyloid formation was reached.
Meloxicam treatment was discontinued, and therapy 
with prednisolone (prednisolone 5  mg tablets; Millpledge 
Veterinary) (0.5 mg/kg PO q24 h) and melphalan (melphalan 
2 mg tablets; Aspen Pharma Trading Ltd.) (3.8 mg/m2 PO 
q24 h) was instigated.
Repeat MRI of the head performed one month after 
diagnosis, immediately prior to radiation therapy (RT) in-
dicated that the extra-axial mass in the left parietal lobe 
was approximately 2 mm longer compared to previous MRI 
and had a very mild mass effect. A computed tomography 
(CT) scan was performed at the same time for 3D confor-
mal radiation planning using Prowess software (Panther 
TPS v 5.4). The gross tumor volume (GTV) included the 
left parietal mass extending into both frontal sinuses and a 
1 cm margin was added for planned tumor volume (PTV). 
Planning achieved 95% dose delivered to PTV using four 
10 MV wedged photon beams (one with split wedge and 
one with a field in field compensation beam). Bolus tissue 
equivalent of 0.8 cm was used on all beams to achieve dose 
distribution. Both eyes and brain were outlined as organs at 
risk. RT was delivered under general anesthesia with a lin-
ear accelerator (Siemens ONCOR Impression Plus) using a 
20 × 2.4 Gy fractionation protocol (on a Monday-to-Friday 
basis for four consecutive weeks; total dose of 48  Gy). 
Positioning was achieved using a thermoplastic beam di-
rectional shell (Oncology Imaging Systems) and vacuum 
F I G U R E  2  Magnetic resonance 
images of the brain of the dog at the level of 
dorsum sellae. Transverse (A) T2W image, 
(B) FLAIR image, (C) T1W image, and 
(D) postcontrast T1W image. A broad-
based, extra-axial mass (white arrow) is 
noted in the left parietal lobe. It is slightly 
heterogeneously hyperintense on T2W and 
FLAIR images, but slightly hypointense 
on the T1W image and has a minimal mass 
effect. The diploe of the dorsal calvarium 
(asterisk) is very heterogeneous due to 
the loss of the normal T2W- and T1W-
hyperintense fat signal in multiple areas. 
D, The transverse T1W postcontrast image 
shows heterogeneous contrast enhancement 
of the diploe (arrowheads). The adjacent 
meninges are thickened and markedly 
contrast enhance, especially dorsal to the 
mass (open arrow). The mass shows slight 
patchy contrast enhancement (white arrow)
(A) (B)
(C) (D)
F I G U R E  3  Representative histopathological photograph 
depicting the population of monomorphic round cells dissecting 
and expanding the medullary cavity. Fragments of devitalized bone 
trabecules are present (asterisk). Hematoxylin and eosin, ×400 
magnification
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bag (Qfix) molded to the shape of the dog's head, clipped to 
a head frame on a flat-topped treatment couch, and verified 
using an electronic portal imaging device and megavoltage 
radiation.
Repeat MRI and CT scans of the head two months after 
completing the course of radiotherapy indicated a possible 
mild decrease in size of the left parietal mass and shrinkage 
of the right frontal sinus mass compared with previous scans 
although new areas of hyperostosis and sclerosis were noted 
in the parietal bone.
Five months after completing the course of RT, a general-
ized tonic-clonic epileptic seizure was reported and the dog 
was re-presented for lethargy. Abdominal ultrasound revealed 
an enlarged and irregular-demarcated right kidney with a het-
erogeneous hypoechoic mass occupying the entire caudal 
pole and extending to the cranial pole. There was extension of 
soft tissue material within the right renal vein and the caudal 
vena cava. CT scan of the thorax detected multiple small soft 
tissue nodules throughout the pulmonary fields. The cytolog-
ical examination of the renal mass was not diagnostic. These 
imaging findings were compatible with primary right renal 
neoplasia with pulmonary metastasis. Renal cell carcinoma 
(RCC) was the main differential diagnosis; however, other 
histotypes could not be excluded. The owner refused further 
investigations, and treatment with oral toceranib phosphate 
was commenced (Palladia 15  mg tablets; Zoetis) (3  mg/kg 
PO three times a week).
Two months later, the dog acutely collapsed and died in 
the household. No postmortem examination was consented 
by the owners.
2 |  DISCUSSION
Solitary plasmacytomas are a myeloid-related disorder that 
can form either in soft tissue as extramedullary plasmacyto-
mas or in bone as solitary osseous plasmacytomas.1 In dogs, 
solitary osseous plasmacytomas have been reported involving 
the axial and appendicular skeleton, as well as the zygomatic 
arch, and ribs.1,2 In humans, solitary osseous plasmacytomas 
are most frequently seen in the thoracic vertebrae, the ribs, 
sternum, clavicle, scapula, or mandible.3 There are no reports 
in veterinary medicine of solitary osseous plasmacytoma af-
fecting the cranial vault.
In the 2016 revision of the World Health Organization 
(WHO) classification of lymphoid neoplasms, plasma cell 
myeloma, solitary plasmacytoma of bone, and extraosseous 
plasmacytoma were classified as mature B-cell neoplasm.4 
Plasma cell neoplasia was excluded from the 2016 WHO 
classification of tumors of the central nervous system.5
Clinical signs associated with solitary osseous plasmacy-
tomas usually relate to the location of the anatomic involve-
ment. These include pain and lameness if the appendicular 
skeleton is affected or neurologic signs if the vertebral col-
umn is involved.1
In a recent review of human solitary plasmacytomas, the 
authors proposed that a biopsy-proven monoclonal plasma 
cell infiltration of a single lesion is required for the diagnosis 
of solitary osseous plasmacytoma. Furthermore, there must 
be absence of end organ damage including hypercalcemia, 
renal dysfunction, and anemia. A single site of involvement 
without any additional lesions on imaging must be demon-
strated. In addition, a diagnostic bone marrow biopsy must 
display <10% of monoclonal plasma cells. Lastly, immuno-
histochemistry staining should be performed to ascertain the 
presence of a monoclonal plasma cell population.6
In veterinary medicine, the diagnosis of solitary osseous 
plasmacytoma and extramedullary plasmacytoma requires 
tissue histology or cytology. In the case of poorly differ-
entiated plasmacytic tumors, immunohistochemical stud-
ies, directed at detecting immunoglobulin, light and heavy 
chains, MM-1/interferon regulatory factor-4 (MUM1/IRF4), 
and thioflavin T, may help to differentiate from other round 
cell tumors. It is paramount to thoroughly stage patients with 
plasmacytomas which are at higher risk for systemic spread 
if local or loco-regional therapy without systemic therapy is 
considered, especially in cases of solitary osseous plasmacy-
toma and gastrointestinal extramedullary plasmacytoma due 
to their relatively high metastatic rate. This should include 
bone marrow aspiration, serum electrophoresis, abdominal 
ultrasound scan, and skeletal survey radiographs to ensure 
the disease is confined to a local site prior to therapy initia-
tion.1 This diagnostic workup was performed in the present 
case, and no evidence of distant neoplastic disease could be 
detected. Therefore, the conducted investigations were suffi-
ciently thorough to support the diagnosis of solitary osseous 
plasmacytoma.
In the treatment of solitary osseous plasmacytomas, RT 
is the mainstay of therapy in humans and is commonly pre-
scribed in pets due to the achievement of good local tumor 
control; however, most solitary osseous plasmacytomas in 
humans may progress to multiple myeloma (MM).1,6 There is 
controversy as to whether systemic chemotherapy using mel-
phalan and prednisolone improves outcome when systemic 
involvement is not documented.1,6
Advanced imaging techniques (such as MRI and CT) 
have greatly improved the diagnosis of intracranial tumors.7 
Nonetheless, a definitive diagnosis requires histopathologi-
cal confirmation. In a study of 40 histologically confirmed 
intracranial tumors, the diagnosis of tumor type based on im-
aging findings was correct in only 70% of the cases.8 None 
of the specimens was diagnosed as plasmacytoma. In two 
other reviews of canine intracranial neoplasia, no descrip-
tion of intracranial or cranial vault plasmocytoma was pro-
vided.7,9 Considering the rarity of the MRI findings in this 
case, differential diagnoses for the osseous changes included 
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mesenchymal neoplasia (such as osteosarcoma or chondro-
sarcoma) and osteomyelitis; and for the parietal cortex mass, 
extension of neoplasia or granuloma formation was the main 
suspicion. Considering the extra-axial appearance of the 
mass in conjunction with the superjacent osseous lesion, me-
ningioma was also considered.10,11
Based on the imaging diagnosis, ascertaining whether the 
osseous lesions were a consequence of the left parietal cor-
tex mass or vice versa was difficult. Calvarial erosion, scle-
rosis, lysis, and hyperostosis associated with meningiomas, 
carcinomas, and glial cell tumors in companion animals and 
humans have been reported.10-14 Histological examination 
in this case suggested that the frontal parietal bone mass 
was the primary lesion and the underlying brain mass was 
amyloid deposit, presumably a complication of the plasmo-
cytic neoplasia. Amyloidosis is histologically characterized 
by the extracellular deposition of insoluble fibrillar pro-
teins. Although the nature of the amyloid deposit was not 
investigated further, we hypothesized this to be local depo-
sition of immunoglobulin light chains.15 The presence of a 
local phenomenon rather than systemic amyloidosis could 
be due to the secretion of poorly soluble immunoglobulins 
with a tendency toward local precipitation.16 Primary local 
extracellular amyloidosis with secondary granulomatous 
inflammation is reported in plasma cell dyscrasias and plas-
mocytic neoplasia in animals.17-21 In the current case, no 
histopathological features compatible with amyloidoma (or 
amyloid tumor) were detected. Nonetheless, this neoplastic 
disease has not been reported in the veterinary literature to 
date. The etiology of the meningeal thickening and contrast 
enhancement detected on MRI was presumed to be reactive 
inflammation secondary to the amyloid deposit, although 
this remains speculative.
The lack of histopathological confirmation of the frontal 
sinus masses remains an intrinsic limitation of this case, al-
though their close proximity on MRI to the left frontal/pa-
rietal bone lesion (with confirmed diagnosis) makes other 
differential diagnoses unlikely.
Another limitation is the lack of definitive diagnosis of the 
right renal growth and the multiple pulmonary nodules. Their 
ultrasonographic and radiological appearance was suggestive 
of RCC and pulmonary metastasis. Most metastasis in a study 
of canine RCC was pulmonary.22 Interestingly, 85% of dogs 
with metastasis at time of diagnosis had evidence of vascular 
invasion on histopathological examination.22 Another study 
revealed sonographic evidence of invasion into the renal 
vein and caudal vena cava, although surgical report did not 
corroborate or refute this finding.23 These facts may support 
the presumed diagnosis of RCC with neighboring vessel in-
vasion. Moreover, the sudden collapse and death of the dog 
could have been associated to rupture of the invaded vessels 
and resultant hemoabdomen. Neurological deterioration 
would have been expected should the death be associated to 
the skull solitary osseous plasmacytoma and/or the amyloid 
tissue. Furthermore, plasma cell neoplasia with metastasis to 
the kidney or lungs has not been reported to date. The major-
ity of solitary osseous plasmacytomas eventually progress to 
systemic MM in people; however, this tends to occur within 
months to years.24 To date, no documented reports of tran-
sition from solitary osseous plasmacytoma to systemic MM 
have been found in the veterinary literature.
3 |  CONCLUSION
Bone mass-like lesions affecting the skull should raise the 
suspicion of solitary osseous plasmacytoma. Nevertheless, 
amyloid deposition should be considered as a possible dif-
ferential diagnosis in cases of extra-axial growths affecting 
the brain, when presented in conjunction with overlying skull 
mass-like growths. Histopathological confirmation and thor-
oughly staging remain mandatory to reach a definitive diag-
nosis. To the authors' knowledge, this is the first description 
of a solitary osseous plasmacytoma with associated amyloid 
deposition affecting the skull of a dog.
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